Adjuvant formulations and their mode of action
Affiliations
- PMID: 1966859
Item in Clipboard
Adjuvant formulations and their mode of action
Semin Immunol.
1990 Sep.
Abstract
We have developed an adjuvant formulation (SAF) consisting of a synthetic muramyl dipeptide analogue (N-acetylmuramyl-L-threonyl-D-isoglutamine) in a squalane-Pluronic polymer emulsion. Used with a variety of antigens SAF elicits cell-mediated immunity and antibodies of protective isotypes (IgG2a in the mouse). SAF augments responses to influenza virus haemagglutinin and hepatitis B virus surface antigen. Vaccines using SAF have protected guinea pigs against genital herpes simplex virus infections and subhuman primates against Epstein-Barr virus and simian immunodeficiency virus infections. Properties of SAF are compared with those of other adjuvants, including lipopolysaccharide analogs, ISCOMs and liposomes.
Similar articles
-
Immunological adjuvants: desirable properties and side-effects.Mol Immunol. 1991 Mar;28(3):279-84. doi: 10.1016/0161-5890(91)90074-t. Mol Immunol. 1991. PMID: 1850114
-
Immunological adjuvants and their modes of action.Arch Immunol Ther Exp (Warsz). 1997;45(2-3):141-7. Arch Immunol Ther Exp (Warsz). 1997. PMID: 9597079 Review.
-
[Enhancement of the activity of hepatitis B virus vaccine by association with murabutide].C R Seances Acad Sci III. 1982 Nov 22;295(10):611-4. C R Seances Acad Sci III. 1982. PMID: 6218866 French.
-
Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.Lab Anim Sci. 1995 Aug;45(4):420-6. Lab Anim Sci. 1995. PMID: 7474883
-
Squalene and squalane emulsions as adjuvants.Methods. 1999 Sep;19(1):87-93. doi: 10.1006/meth.1999.0832. Methods. 1999. PMID: 10525443 Review.
Cited by
-
Liposome-nucleic acid immunotherapeutics.Expert Opin Drug Deliv. 2008 Jan;5(1):11-24. doi: 10.1517/17425247.5.1.11. Expert Opin Drug Deliv. 2008. PMID: 18095926 Free PMC article. Review.
-
Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates.Infect Immun. 1994 Mar;62(3):1026-31. doi: 10.1128/iai.62.3.1026-1031.1994. Infect Immun. 1994. PMID: 8112836 Free PMC article.
-
Enhancement of in vivo and in vitro immune functions by a conformationally biased, response-selective agonist of human C5a: implications for a novel adjuvant in vaccine design.Vaccine. 2009 Dec 11;28(2):463-9. doi: 10.1016/j.vaccine.2009.10.029. Epub 2009 Oct 15. Vaccine. 2009. PMID: 19836478 Free PMC article.
-
The effect of the nonionic block copolymer pluronic P85 on gene expression in mouse muscle and antigen-presenting cells.Biomaterials. 2009 Feb;30(6):1232-45. doi: 10.1016/j.biomaterials.2008.10.064. Epub 2008 Dec 7. Biomaterials. 2009. PMID: 19064283 Free PMC article.
-
Molecular adjuvants and immunomodulators: new approaches to immunization.Clin Microbiol Rev. 1994 Jul;7(3):277-89. doi: 10.1128/CMR.7.3.277. Clin Microbiol Rev. 1994. PMID: 7923049 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical